BIOGENIC, A LEADING PLAYER IN THAILAND'S CANCER DIAGNOSTICS MARKET, FOCUSES ON HIGH MEDICAL VALUE PRODUCTS FROM ADVANCED TECHNOLOGIES SUCH AS MOLECULAR DIAGNOSTICS, DIGITAL PCR, AND AUTOMATION TO SERVE THAILAND'S HEALTHCARE PROFESSIONALS AND RESEARCHERS. WE PROVIDE CUTTING-EDGE SOLUTIONS TO IMPROVE DIAGNOSTIC ACCURACY AND EFFICIENCY, ENHANCING PATIENT OUTCOMES. OUR COMMITMENT TO INNOVATION AND QUALITY SUPPORTS HEALTHCARE PROVIDERS IN THEIR RESEARCH AND CLINICAL PRACTICE. WE CONTINUE TO EXPAND OUR PORTFOLIO TO MEET THE EVOLVING NEEDS OF THE MEDICAL COMMUNITY IN THAILAND AND BEYOND.
"Each year, BIOCARTIS recognizes top performing distribution partner in appreciation of their commitment. BIOGENIC has once again achieved impressive perfrormance with Biocartis in 2021, 2022."
BIOGENIC is honored to receive the Distributor of the Year award from BIOCARTIS for two consecutive years, 2021 and 2022. This prestigious award highlights our outstanding sales achievements, remarkable growth, and unwavering dedication to customer service and satisfaction.
"We are thrilled to be recognized by BIOCARTIS for our exceptional performance and commitment. This award is a testament to the hard work and dedication of our team, as well as our strong partnership with BIOCARTIS," said a BIOGENIC spokesperson.
At BIOGENIC, we strive to provide innovative solutions and unparalleled support to our customers. This recognition motivates us to continue our mission of excellence in the industry.